Unleashing Europe’s Biopharmaceutical Innovation Potential: What can be done to accelerate AIDS vaccine research and development?

Abstract

Europe’s significant scientific capacity could prove pivotal in the quest for an AIDS vaccine. This policy brief discusses key challenges, such as a translational research gap, that must be addressed to best harness Europe’s expertise.

Citation

IAVI Insights: Policy Brief 18. International AIDS Vaccine Initiative (IAVI), New York, NY, USA. 8 pp.

Unleashing Europe’s Biopharmaceutical Innovation Potential: What can be done to accelerate AIDS vaccine research and development?

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.